Avapritinib, Avapritinib, Avapritinib
BLU-285-3101
Phase 2 small_molecule active
Quick answer
Avapritinib, Avapritinib, Avapritinib for Solid Tumors Dependent on KIT or PDGFRA Signaling is a Phase 2 program (small_molecule) at Blueprint Medicines (Netherlands) B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Blueprint Medicines (Netherlands) B.V.
- Indication
- Solid Tumors Dependent on KIT or PDGFRA Signaling
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active